While 6-month mortality for STEMI continued to decline until 2015, mortality improvements for NSTEMI patients appear to have plateaued since 2010.
Answers are grounded in this paper and cite their sources.
NSTEMI mortality plateau since 2010 warrants renewed prevention efforts; leaves open whether targeted trials can resume prior declines.
Over the past 20 years, 6-month mortality after acute myocardial infarction has decreased considerably for patients with STEMI and NSTEMI. Mortality figures continued to decline in patients with STEMI until 2015, whereas mortality in patients with NSTEMI appears stable since 2010.
No takes yet. Share an insight, caveat, or question.
Puymirat et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: